Is GLP-1 a Shot? Exploring the Role of GLP-1 Agonists in Weight Loss and Diabetes Management

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

GLP-1 receptor agonists—yes, they do come as shots—have transformed weight loss and diabetes management since their introduction as diabetes treatments in the early 2000s. These medications activate the glucagon-like peptide-1 receptor in your brain and pancreas, signaling fullness and improving blood sugar control. PlexusDx delivers both injectable and oral GLP-1 options from licensed 503A compounding pharmacies, personalized to your genetic blueprint.

Understanding GLP-1: How Injectable Medications Work for Weight Loss

GLP-1 agonists are hormone-mimicking drugs that slow your stomach's emptying rate, increase feelings of satiety, and reduce hunger signals in your brain. When you inject semaglutide, the medication reaches your bloodstream directly, bypassing digestion and delivering consistent drug levels within hours. Clinical trials have shown that GLP-1 injection users lose an average of 10–15% of body weight over 68 weeks, with some achieving reductions exceeding 20% when combined with lifestyle changes.

The injectable form allows for precise dose control and weekly or biweekly dosing schedules, making it easier to track your progress and adjust your regimen without daily pill-taking. PlexusDx compounded semaglutide injection is manufactured in licensed 503A pharmacies and available to all 50 states without insurance requirements, at $189/mo month-to-month, or from $149/mo on the 6-month plan. Your dose may need to go up as your body builds tolerance, but your price won't change—a core PlexusDx commitment to affordability and transparency.

Oral GLP-1 Options: An Alternative to Injections for Weight Management

Not everyone prefers needles, which is why PlexusDx also offers oral semaglutide formulations that deliver the same GLP-1 activation through a tablet form. Oral versions require more frequent dosing—typically daily—and may have slightly lower bioavailability than injections, meaning more of the drug must be taken to achieve similar blood levels. Oral semaglutide at PlexusDx is $289/mo month-to-month (or $249/mo on the 6-month plan) and provides the same metabolic benefits as the injectable form, just with a different administration method.

The choice between injectable and oral depends on your lifestyle, needle comfort, and dosing preferences. Both forms can be paired with the PlexusDx Precision Peptide Genetic Test to map your individual response to GLP-1 therapy across 14 metabolic pathways and 150+ genetic insights.

Dual-Compound GLP-Squared: Combining Semaglutide and Tirzepatide for Enhanced Results

PlexusDx offers an advanced option called GLP-Squared—a dual-compound injection that combines semaglutide and tirzepatide in a single formulation. While semaglutide targets the GLP-1 receptor alone, tirzepatide activates both GLP-1 and GIP receptors, triggering a broader metabolic response. Studies comparing dual-agonist therapy to single-agent GLP-1 show weight loss reductions of 20–22% over 72 weeks, outperforming semaglutide alone in many participants.

GLP-Squared injection is $289/mo month-to-month (or $249/mo on the 3-month plan), offering a premium personalization option for patients who have plateaued on monotherapy or seek more aggressive metabolic intervention. An oral dual-compound version (GLP-Squared Oral) is also available starting at $389/mo (or $369/mo on the 3-month plan) for those who prefer daily tablets.

Genetic Personalization: Why Your GLP-1 Response Is Unique to You

Not everyone responds equally to GLP-1 therapy—your genes influence how well semaglutide or tirzepatide works for your weight loss goals. The PlexusDx Precision Peptide Genetic Test analyzes key variants in your GIPR, FTO, and MC4R genes, revealing how your body's peptide pathways interact with GLP-1 agonist treatment. Carriers of the GLP1R rs6923761 variant, for example, may experience stronger satiety signals, while FTO rs9939609 carriers often have baseline differences in appetite regulation that influence medication response.

Available for $298, the Precision Peptide test provides PlexusDx prescribers with actionable insights to optimize your dose, select between semaglutide and tirzepatide, or recommend combination therapy. This precision approach removes guesswork from GLP-1 selection and increases the likelihood of sustained weight loss success.

Cost, Access, and Insurance Coverage for GLP-1 Therapy at PlexusDx

PlexusDx removes traditional barriers to GLP-1 access by serving all 50 states without insurance requirements or membership fees. Compounded semaglutide injection is $189/mo month-to-month, or from $149/mo on the 6-month plan across three commitment tiers, with consistent pricing regardless of your dose escalation—reflecting PlexusDx's philosophy that effective weight loss should not become unaffordable as you progress. HSA and FSA accounts are eligible for all PlexusDx medications, further reducing out-of-pocket costs.

Unlike branded GLP-1 products that can exceed $1,000 monthly, PlexusDx compounded formulations deliver pharmaceutical-grade semaglutide, tirzepatide, and dual-compound options at a fraction of the cost. A patient initiating therapy with compounded semaglutide injection at $189/mo (or $149/mo on the 6-month plan) and adding the Precision Peptide test ($298 one-time) invests less than $350 in their first month while gaining personalized guidance for long-term success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Are GLP-1 medications always injected, or can I take them as pills?

GLP-1 medications come in both forms. PlexusDx offers injectable semaglutide (at $189/mo month-to-month, or from $149/mo on the 6-month plan) and oral semaglutide (at $289/mo month-to-month, or from $249/mo on the 6-month plan), giving you flexibility based on your comfort and lifestyle. Both deliver the same metabolic benefits; the choice is personal preference and ease of adherence.

How much weight can I expect to lose with semaglutide injection?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide from PlexusDx safe and regulated?

Yes. PlexusDx sources all GLP-1 medications from licensed 503A compounding pharmacies that operate under FDA oversight and state pharmacy board regulations. While compounded medications are not FDA-approved for specific indications, they are manufactured to pharmaceutical-grade standards and legally available for off-label use.

Do I need insurance or membership to access PlexusDx GLP-1 therapy?

No. PlexusDx serves all 50 states without insurance requirements, membership fees, or subscription locks. Your compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan, your dose may increase, but your price stays the same—making long-term weight loss affordable and transparent.

What does the PlexusDx Precision Peptide Genetic Test tell me about GLP-1 response?

The $298 test maps 49 peptides across 14 metabolic pathways, including GIPR, FTO, and MC4R variants that influence your appetite regulation, satiety signaling, and GLP-1 medication response. Results guide your prescriber in selecting semaglutide, tirzepatide, or dual-compound therapy to maximize your weight loss success.

Related Reading

• Glp 1 Receptor Agonists For Weight Loss
• Glp 1 For Weight Loss 2
• Glp 1 Weight Loss Before And After
• Glp 1 Dosage For Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.